Pfizer and Protalix BioTherapeutics have obtained approval from the Brazilian National Health Surveillance Agency for Uplyso (alfataliglicerase) as type I Gaucher disease therapy. Uplyso, referred to as Elelyso (taliglucerase alfa) ...
Tags: Pfizer, Protalix, Protalix BioTherapeutics
Pfizer and Protalix BioTherapeutics have announced FDA approval of Elelyso (taliglucerase alfa) for injection to treat type 1 Gaucher disease. Elelyso, derived from ProCellEx, is an enzyme replacement therapy (ERT) for the long-term ...
Tags: Protalix/Pfizer Gaucher Drug, Pfizer and Protalix BioTherapeutics